1. Generics Bulletin
  2. >>Business
  3. >>Deals

Taro Penalties Exceed $400m As It Admits Fixing Prices With Sandoz

Criminal Penalty And Civil Damages Announced

 
• By Dean Rudge

In the latest development arising from ongoing generic pricing investigations in the US, Taro has admitted to fixing prices, allocating customers and rigging bids for generic medicines, under a conspiracy with multiple firms, including Sandoz.

Department of Justice
Taro has agreed to cooperate fully with the DoJ Antitrust Division’s ongoing criminal investigation • Source: Shutterstock

Taro Pharmaceutical Industries’ US subsidiary has become the fifth pharmaceutical company to admit that it conspired to fix the prices of generic medicines, agreeing to pay a $205.7m criminal penalty as part of a three-year deferred prosecution agreement with the US Department of Justice.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business